BridgeMD
Compares treatment options for Ventricular Tachycardia
Official title DEEP Substrate Mapping Versus Activation Mapping for VT
ClinicalTrials.gov ID: NCT06371729
What this study is testing
- What it's testing
- Substrate-based DEEP mapping and activation mapping are two of the main techniques used for guiding ventricular tachycardia (VT) ablation. There is no data comparing directly the extent of applicability, procedural results, and the long-term outcomes between the two mapping strategies.This randomized clinical trial aims to test whether activation mapping is superior to DEEP mapping to reduce ventricular tachycardia recurrence.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with an implanted ICD (all brands)
- Patients with the indication for Ventricular Tachycardia Ablation (both first and redo procedures), supported by EnSite 3D mapping system, for the...
- Age: 18 years or more.
- A participant is willing and able to give informed consent for participation in the trial and is available to respect the assessments described in...
You likely can't join if
- Contraindication to anticoagulants.
- Presence of thrombi.
- Presence of Mitral and Aortic prosthetic valve.
- Recent (less than 3 months) myocardial infarction, unstable angina, or Coronary Artery Bypass.
- Ventricular Tachycardia caused by reversible pathology.
- Life expectancy less than 1 year, according to the investigator.
See the full eligibility criteria
- Patients with an implanted ICD (all brands)
- Patients with the indication for Ventricular Tachycardia Ablation (both first and redo procedures), supported by EnSite 3D mapping system, for the following disease aetiologies: previous MI, myocarditis, arrhythmogenic...
- Age: 18 years or more.
- A participant is willing and able to give informed consent for participation in the trial and is available to respect the assessments described in the protocol and informed consent form.
- Contraindication to anticoagulants.
- Presence of thrombi.
- Presence of Mitral and Aortic prosthetic valve.
- Recent (less than 3 months) myocardial infarction, unstable angina, or Coronary Artery Bypass.
- Ventricular Tachycardia caused by reversible pathology.
- Life expectancy less than 1 year, according to the investigator.
- Contraindications to the use of ablation/diagnostic catheters or to cardiac catheterization.
- Female participant who is pregnant, lactating, or planning pregnancy during the course of the trial.
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Lombardy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Lombardy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.